Deep brain electrical neurofeedback allows Parkinson patients to control pathological oscillations and quicken movements
Open Access
- 12 April 2021
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-10
Abstract
Parkinsonian motor symptoms are linked to pathologically increased beta-oscillations in the basal ganglia. While pharmacological treatment and deep brain stimulation (DBS) reduce these pathological oscillations concomitantly with improving motor performance, we set out to explore neurofeedback as an endogenous modulatory method. We implemented real-time processing of pathological subthalamic beta oscillations through implanted DBS electrodes to provide deep brain electrical neurofeedback. Patients volitionally controlled ongoing beta-oscillatory activity by visual neurofeedback within minutes of training. During a single one-hour training session, the reduction of beta-oscillatory activity became gradually stronger and we observed improved motor performance. Lastly, endogenous control over deep brain activity was possible even after removing visual neurofeedback, suggesting that neurofeedback-acquired strategies were retained in the short-term. Moreover, we observed motor improvement when the learnt mental strategies were applied 2 days later without neurofeedback. Further training of deep brain neurofeedback might provide therapeutic benefits for Parkinson patients by improving symptom control using strategies optimized through neurofeedback.Keywords
All Related Versions
This publication has 24 references indexed in Scilit:
- Systematic review of levodopa dose equivalency reporting in Parkinson's diseaseMovement Disorders, 2010
- Goal-directed and habitual control in the basal ganglia: implications for Parkinson's diseaseNature Reviews Neuroscience, 2010
- Deep brain stimulation can suppress pathological synchronisation in parkinsonian patientsJournal of Neurology, Neurosurgery & Psychiatry, 2010
- Coupling between Beta and High-Frequency Activity in the Human Subthalamic Nucleus May Be a Pathophysiological Mechanism in Parkinson's DiseaseThe Journal of Neuroscience, 2010
- Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing resultsMovement Disorders, 2008
- Habits, Rituals, and the Evaluative BrainAnnual Review of Neuroscience, 2008
- High-Frequency Stimulation of the Subthalamic Nucleus Suppresses Oscillatory Activity in Patients with Parkinson's Disease in Parallel with Improvement in Motor PerformanceThe Journal of Neuroscience, 2008
- Pathological synchronization in Parkinson's disease: networks, models and treatmentsTrends in Neurosciences, 2007
- Modulation of beta oscillations in the subthalamic area during motor imagery in Parkinson's diseaseBrain, 2005
- Stages in the development of Parkinson’s disease-related pathologyCell and tissue research, 2004